4//SEC Filing
Sanford Svai S 4
Accession 0000950170-23-071474
CIK 0001856725other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:05 PM ET
Size
16.5 KB
Accession
0000950170-23-071474
Insider Transaction Report
Form 4
Sanford Svai S
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-12-16+171,500→ 171,500 totalExercise: $2.84Exp: 2033-03-26→ Class A Common Stock (171,500 underlying) - Award
Stock Option (Right to Buy)
2023-12-16+83,724→ 83,724 totalExercise: $2.84Exp: 2031-07-28→ Class A Common Stock (83,724 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-12-16−171,500→ 34,300 totalExercise: $5.44Exp: 2033-03-26→ Class A Common Stock (171,500 underlying) - Award
Stock Option (Right to Buy)
2023-12-16+58,334→ 58,334 totalExercise: $2.84Exp: 2032-03-21→ Class A Common Stock (58,334 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-12-16−58,334→ 41,666 totalExercise: $13.21Exp: 2032-03-21→ Class A Common Stock (58,334 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-12-16−83,724→ 127,788 totalExercise: $9.44Exp: 2031-07-28→ Class A Common Stock (83,724 underlying)
Footnotes (5)
- [F1]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.
- [F2]The remaining shares subject to the option are fully vested and exercisable as of the Repricing Date.
- [F3]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on December 16, 2023 (the "Repricing Date"). Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $2.84 per share, the closing price of the Issuer's Common Stock on the Repricing Date. There is no change to the expiration dates or the vesting schedule of the repriced options.
- [F4]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.
- [F5]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001591411
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:05 PM ET
- Size
- 16.5 KB